2022
DOI: 10.1007/s12350-020-02385-w
|View full text |Cite
|
Sign up to set email alerts
|

Spectrum of radionuclide perfusion study abnormalities in takotsubo cardiomyopathy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
4
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 10 publications
(5 citation statements)
references
References 39 publications
0
4
0
Order By: Relevance
“…The role of perfusion abnormalities in TTS is a matter of debate as both increased and decreased perfusion have been described by radionucleotide perfusion studies (RPS). Anderson et al analyzed the Intermountain Healthcare electronic medical records which contained 16 patients with TTS who had RPS [ 2 ]. The tracers used were 82 Rb PET/CT in eight, 99m Tc sestamibi SPECT in six, and 201 Tl SPECT in two.…”
Section: Discussionmentioning
confidence: 99%
“…The role of perfusion abnormalities in TTS is a matter of debate as both increased and decreased perfusion have been described by radionucleotide perfusion studies (RPS). Anderson et al analyzed the Intermountain Healthcare electronic medical records which contained 16 patients with TTS who had RPS [ 2 ]. The tracers used were 82 Rb PET/CT in eight, 99m Tc sestamibi SPECT in six, and 201 Tl SPECT in two.…”
Section: Discussionmentioning
confidence: 99%
“…Nuclear medicine techniques represent the non-invasive gold-standard for evaluation of non-endothelial dependent microvascular function in absence of obstructive coronary artery disease (CAD) by measuring absolute MBF and MBF reserve [ 68 ]. Small studies have demonstrated minor perfusion abnormalities in patients with TTS by 18-fluorodeoxyglucose (FDG) positron emission tomography (PET) or single-photon emission computed tomography (SPECT) imaging [ 69 ]. Nuclear medicine imaging has proven its worth also in giving insight about the physiopathology of TTS, showing an “inverse metabolic perfusion mismatch” characterized by an impaired metabolism in the involved LV regions with normal MBF at rest [ 70 , 71 , 72 ].…”
Section: Coronary Microvascular Dysfunctionmentioning
confidence: 99%
“…Stressors vary widely among reports of TTC cases and include natural disasters to weddings and surprise parties, from surgery and anesthesia to thyrotoxicosis [19] and sepsis, from the postpartum period [20,21] to COVID-19 infection [22], from subarachnoid hemorrhage and stroke to pancreatitis and cholecystitis, from pheochromocytoma to neoplasm and cancer-related therapies, and so on [23]. The reaction to stressors depends on individual factors influencing both catecholamine production and myocyte and microvascular response to sympathetic stimulation [24], with estrogen deficiency, genetic factors, and neurologic and psychiatric disorders being predisposing factors to mental and physical triggers [25][26][27][28][29]. Despite the clinical presentation usually mimicking ACS [30], with patients often presenting with chest pain, followed by dyspnea and syncope [31], having electrocardiographic abnormalities (ST-segment elevation, ST-segment depression, T-wave negative conversion, and QT prolongation) [32] and showing a mild elevation of myocardionecrosis enzyme levels, as well as the marked elevation of brain natriuretic peptide (BNP) and N-terminal pro-BNP [33][34][35][36], TTC is formally considered a benign self-limiting state presenting a favorable prognosis [37] and it is generally characterized by a temporary impairment with complete recovery within 3 weeks.…”
Section: Introductionmentioning
confidence: 99%